Andy Chevigné and his workforce, RTI-5152-12 is postulated to improve the levels of opioid peptides that bind to classical opioid receptors from the brain, causing heightened painkilling action. The LIH-RTI study groups proven a collaboration arrangement and filed a joint patent applicati